To conclude, these findings implicate a potential role for PD-1 and TIGIT for maintaining immune tolerance in the oesophagus, suggesting that these ICs may be appropriate ICs to target in oesophageal cancers. The gene discussed is TIGIT; the disease is carcinoma of esophagus.